156 related articles for article (PubMed ID: 35030282)
41. Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages.
Suárez-Cabrera A; Fiallo-Suárez DV; Stuckey R; Uroz-de la Iglesia ML; Florido Y; Lemes-Castellano A; Perera-Álvarez MÁ; Luzardo-Henríquez H; de la Nuez H; Fernández-Caldas P; de la Iglesia S; Gómez-Casares MT; Bilbao-Sieyro C
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892513
[TBL] [Abstract][Full Text] [Related]
42. A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia.
Tecchio C; Nichele I; Mosna F; Zampieri F; Leso A; Al-Khaffaf A; Veneri D; Andreini A; Pizzolo G; Ambrosetti A
Eur J Haematol; 2011 Sep; 87(3):228-34. PubMed ID: 21595749
[TBL] [Abstract][Full Text] [Related]
43. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
[TBL] [Abstract][Full Text] [Related]
44. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
45. [News in therapeutic management of chronic lymphoid leukemia].
Michallet AS; Salles G; Coiffier B; Michallet M
Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
[TBL] [Abstract][Full Text] [Related]
46. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
47. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
48. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
[TBL] [Abstract][Full Text] [Related]
50. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.
Andersen MA; Vojdeman FJ; Andersen MK; Brown Pde N; Geisler CH; Weis Bjerrum O; Niemann CU
Leuk Lymphoma; 2016 Jul; 57(7):1592-9. PubMed ID: 26850493
[TBL] [Abstract][Full Text] [Related]
51. Chronic lymphocytic leukemia and prognostic factors.
Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
[TBL] [Abstract][Full Text] [Related]
52. Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia.
Schlosser P; Schiwitza A; Klaus J; Hieke-Schulz S; Szic KSV; Duyster J; Trepel M; Zirlik K; Schumacher M; Claus R
Ann Hematol; 2024 May; 103(5):1613-1622. PubMed ID: 38308707
[TBL] [Abstract][Full Text] [Related]
53. A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression.
Abrisqueta P; Medina D; Villacampa G; Lu J; Alcoceba M; Carabia J; Boix J; Tazón-Vega B; Iacoboni G; Bobillo S; Marín-Niebla A; González M; Zenz T; Crespo M; Bosch F
Blood Adv; 2022 Nov; 6(21):5763-5773. PubMed ID: 35973197
[TBL] [Abstract][Full Text] [Related]
54. Multivariable model consisting of clinical and biological markers for time to first treatment in CLL patients: Preliminary results from single centre experience.
Trajkova S; Cevreska L; Pivkova-Veljanovska A; Ivanovski M; Dukovski D; Popova-Simjanovska M; Cadievski L; Eftimov A; Dimovski A; Panovska-Stavridis I
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):39-47. PubMed ID: 24566014
[TBL] [Abstract][Full Text] [Related]
55. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
56. Chronic lymphocytic leukemia in a young population.
Alshemmari SH; Hamdah A; Pandita R; Kunhikrishnan A
Leuk Res; 2021 Nov; 110():106668. PubMed ID: 34492597
[TBL] [Abstract][Full Text] [Related]
57. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
58. Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
Baliakas P; Hadzidimitriou A; Sutton LA; Rossi D; Minga E; Villamor N; Larrayoz M; Kminkova J; Agathangelidis A; Davis Z; Tausch E; Stalika E; Kantorova B; Mansouri L; Scarfò L; Cortese D; Navrkalova V; Rose-Zerilli MJ; Smedby KE; Juliusson G; Anagnostopoulos A; Makris AM; Navarro A; Delgado J; Oscier D; Belessi C; Stilgenbauer S; Ghia P; Pospisilova S; Gaidano G; Campo E; Strefford JC; Stamatopoulos K; Rosenquist R;
Leukemia; 2015 Feb; 29(2):329-36. PubMed ID: 24943832
[TBL] [Abstract][Full Text] [Related]
59. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia].
Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
[TBL] [Abstract][Full Text] [Related]
60. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]